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Abstract
The long-term consequences of traumatic brain injury (TBI), specifically the detrimental effects of inflammation on the
neurogenic niches, are not very well understood. In the present in vivo study, we examined the prolonged pathological
outcomes of experimental TBI in different parts of the rat brain with special emphasis on inflammation and neurogenesis.
Sixty days after moderate controlled cortical impact injury, adult Sprague-Dawley male rats were euthanized and brain
tissues harvested. Antibodies against the activated microglial marker, OX6, the cell cycle-regulating protein marker, Ki67,
and the immature neuronal marker, doublecortin, DCX, were used to estimate microglial activation, cell proliferation, and
neuronal differentiation, respectively, in the subventricular zone (SVZ), subgranular zone (SGZ), striatum, thalamus, and
cerebral peduncle. Stereology-based analyses revealed significant exacerbation of OX6-positive activated microglial cells in
the striatum, thalamus, and cerebral peduncle. In parallel, significant decrements in Ki67-positive proliferating cells in SVZ
and SGZ, but only trends of reduced DCX-positive immature neuronal cells in SVZ and SGZ were detected relative to sham
control group. These results indicate a progressive deterioration of the TBI brain over time characterized by elevated
inflammation and suppressed neurogenesis. Therapeutic intervention at the chronic stage of TBI may confer abrogation of
these deleterious cell death processes.
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Introduction
In the United States alone, an estimated 1.7 million people
suffer from traumatic brain injury (TBI), and nearly 52,000 deaths
a year, accounting for 30% of all injury-related deaths [1].
Annually, the cost of TBI related expenses is estimated to be
around 52 billion dollars [2,3]. Patients who survive head injuries
often present with disabilities persisting up to decades after the
injury [4]. Although the severity of disabilities varies, which may
be directly associated with the severity of the injury itself [5], the
most common disabilities include sensory-motor problems, learn-
ing and memory deficits, anxiety, and depression [5,6]. Notably,
TBI may predispose long-term survivors to age-related neurode-
generative diseases such as Alzheimer’s disease, Parkinson’s
disease, and post-traumatic dementia [5,6,7,8,9,10].
Long-term neurological deficits from TBI are associated with
neuroinflammation, and may aggravate over time to more severe
secondary injuries, making prevention and treatment a very
complex task [1,11,12,13,14]. Currently, a very well characterized
TBI model for chronic brain atrophy, which addresses proximal
and distal subcortical regions vulnerable to injury, is not available.
An in-depth histological examination of the brain at the chronic
stage of TBI should provide insights into identifying therapeutic
targets amenable to treatment interventions even when initiated at
this late phase of disease progression. Unfortunately to date, many
studies concentrate on specific subcortical regions, while others
focus only on white matter, making it difficult to translate the
findings on pathological mechanisms and therapies generated in
TBI animal models to clinical applications [15,16,17,18]. A better
understanding of the neuropathology propagation associated with
TBI, through investigations of neuro-inflammatory mechanisms
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will allow us to efficiently manage and treat the evolution of TBI-
secondary neuropathologies and cognitive disabilities after the
acute phase [11,19]. In the present in vivo study, the neuro-
inflammatory responses in subcortical regions, such as the dorsal
striatum, thalamus, and white matter as corpus callosum,
hippocampal fimbria-fornix, and cerebral peduncle were charac-
terized in chronic TBI. Additionally, neuronal cell loss, cell
proliferation and neuronal differentiation were examined in
neurogenic niches to assess the detrimental influence of progressive
secondary injury in these vital regenerative areas of the brain. Our
overarching theme advances the concept that a massive neuroin-
flammation after TBI represents a second wave of cell death that
impairs the proliferative capacity of cells, and impedes the
regenerative capacity of neurogenesis in chronic TBI. Accordingly,
we embarked on this study to test the hypothesis that chronic TBI-
induced neuroinflammation interfered endogenous repair mech-
anisms.
Materials and Methods
Subjects
Experimental procedures were approved by the University of
South Florida Institutional Animal Care and Use Committee
(IACUC). All animals were housed under normal conditions
(20uC, 50% relative humidity, and a 12-h light/dark cycle) All
studies were performed by personnel blinded to the treatment
condition.
Surgical Procedures
Ten-week old Sprague–Dawley rats (n = 24) were subjected to
either TBI using a controlled cortical impactor (CCI) (n = 12) or
sham control (no TBI) (n = 12) (Pittsburgh Precision Instruments,
Inc, Pittsburgh, PA). Deep anesthesia was achieved using 1–2%
isoflurane, and it was maintained using a gas mask. All animals
were fixed in a stereotaxic frame (David Kopf Instruments,
Tujunga, CA, USA). After exposing the skull, coordinates of
20.2 mm anterior and +0.2 mm lateral to the midline were used
and impacted the brain at the fronto-parietal cortex with a velocity
of 6.0 m/s reaching a depth of 1.0 mm below the dura matter
layer and remained in the brain for 150 milliseconds (ms). The
impactor rod was angled 15u degrees vertically to maintain a
perpendicular position in reference to the tangential plane of the
brain curvature at the impact surface. A linear variable
displacement transducer (Macrosensors, Pennsauken, NJ), which
was connected to the impactor, measured the velocity and
duration to verify consistency. Sham control injury surgeries
consisted of animals exposed to anesthesia, scalp incision,
craniectomy, and suturing. An electric drill was used to perform
the craniectomy of about 2.5 mm radius with coordinates
calculated from the bregma at 20.2 anterior and +0.2 mm lateral
right. An automated thermal blanket pad and a rectal thermom-
eter allowed maintenance of body temperature within normal
limits. All animals were closely monitored post-operatively with
weight and health surveillance recording as per IACUC guide-
lines. Rats were kept hydrated at all times, and the analgesic
ketoprofen was administered after TBI surgery and as needed
thereafter. Pre and post TBI, rats were fed regular rodent diet
(Harlan 2018, Harlan).
Hematoxylin and Eosin Analysis
Hematoxylin and eosin (H&E) staining was performed to
confirm the core impact injury of our TBI model. As shown in our
previous studies [3,5], we also demonstrated here that the primary
damage produced by the CCI TBI model was to the fronto-
parietal cortex. In addition, H&E staining was analyzed in the
hippocampus to reveal secondary cell loss. Starting at coordinates
AP-2.0 mm and ending at AP-3.8 mm from bregma, coronal
brain sections (40 mm) covering the dorsal hippocampus were
selected. A series of 6 sections per rat was processed for staining.
Cells presenting with nuclear and cytoplasmic staining (H&E) were
manually counted in the CA3 neurons. CA3 cell counting spanned
the whole CA3 area, starting from the end of hilar neurons to the
beginning of curvature of the CA2 region in both the ipsilateral
and contralateral side. Sections were examined with Nikon Eclipse
600 microscope at 20X All data are represented as mean values
6SEM, with statistical significance set at p,0.05.
Immunohistochemistry
Under deep anesthesia, rats were sacrificed 8 weeks after TBI
surgery, and perfused through the ascending aorta with 200 ml of
ice cold phosphate buffer saline (PBS), followed by 200 ml of 4%
paraformaldehyde (PFA) in PBS. Brains were removed and post-
fixed in the same fixative for 24 hours followed by 30% sucrose in
phosphate buffer (PB) for 1 week. Coronal sectioning was carried
out at a thickness of 40 mm by cryostat. H&E staining was done on
every sixth coronal section spanning the dorsal hippocampus.
Staining for the cell cycle–regulating protein Ki67, DCX, and
OX6 was done on every sixth coronal section throughout the
entire striatum and dorsal hippocampus. Sixteen free-floating
coronal sections (40 mm) were incubated in 0.3% hydrogen
peroxide (H2O2) solution followed by 1-h of incubation in blocking
solution (0.1 M phosphate-buffered saline (PBS) supplemented
with 3% normal goat serum and 0.2% Triton X-100). Sections
were then incubated overnight with Ki67 (1:400 Nocastra), DCX
(1:150 Santa Cruz), and OX6 (major histocompatibility complex
or MHC class II; 1:750 BD) antibody markers in PBS supple-
mented with 3% normal goat serum and 0.1% Triton X-100.
Sections were then washed and biotinylated secondary antibody
(1:200; Vector Laboratories, Burlingame, CA) in PBS supple-
mented with 3% normal goat serum, and 0.1% Triton X-100 was
applied for 1 h. Next, the sections were incubated for 60 minutes
in avidin–biotin substrate (ABC kit, Vector Laboratories, Burlin-
game, CA). All sections were then incubated for 1 minute in 3,30-
diaminobenzidine (DAB) solution (Vector Laboratories). Sections
were then mounted onto glass slides, dehydrated in ethanol and
xylene, and cover-slipped using mounting medium.
Stereological Analysis
Unbiased stereology was performed on brain sections immu-
nostained with OX6, Ki67 and DCX. Sets of 1/6 section, about
240 mm apart, were taken from the brain spanning AP –0.2 mm to
AP –3.8 mm in all 24 rats. Activated microglia cells, cell
proliferation, and differentiation into immature neurons were
visualized by staining with OX6, Ki67, and DCX, respectively.
Positive stains were analyzed with a Nikon Eclipse 600 microscope
and quantified using Stereo Investigator software, version 10
(MicroBrightField, Colchester, VT). The estimated volume of
OX6-positive cells was examined using the Cavalieri estimator
probe of the unbiased stereological cell technique [20] revealing
the volume of OX6 in the cortex, striatum, thalamus, fornix,
cerebral peduncle, and corpus callosum. Ki67 [21] and DCX
positive cells were counted within the subgranular zone (SGZ) and
the subventricular zone (SVZ), in both hemispheres (ipsilateral and
contralateral), using the optical fractionator probe of unbiased
stereological cell counting technique. The sampling was optimized
to count at least 300 cells per animal with error coefficients less
than 0.07. Each counting frame (1006100 mm for OX6, Ki67,
and DCX) was placed at an intersection of the lines forming a
Chronic Inflammatory and Neurogenic Effects of TBI
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virtual grid (1256125 mm), which was randomly generated and
placed by the software within the outlined structure. Section
thickness was measured in all counting sites.
Statistical Analysis
For data analyses, contralateral and ipsilateral corresponding
brain areas were used as raw data providing 2 sets of data per
treatment condition (TBI vs. sham control), therefore one-way
analysis of variance (ANOVA) was used for group comparisons,
followed by subsequent pairwise comparisons; post hoc tests
Bonferonni test. All data are represented as mean values with
6SEM. Statistical significance was set at p,0.05 for all analyses.
Results
In the preliminary analyses of the data, comparisons between
sham control ipsilateral and sham control contralateral side, across
all brain regions studied, did not significantly differ (p.0.05).
Thus, the data from both sides of the sham group were combined.
Pair-wise comparisons are summarized in the Tables S1, S2, S3,
S4, S5, S6, S7, S8, S9, including neuroinflammation in different
regions of the brain (cortex, Table S1; striatum, Table S2;
thalamus, Table S3; corpus callosum, Table S4; cerebral
peduncle, Table S5; fornix, Table S6), CA3 neuronal cell loss
(Table S7), cell proliferation in SVZ (Table S8), and cell
proliferation in SGZ (Table S9).
Upregulation of MHCll+ activated Microglia Cells in
Chronic TBI
To test the hypothesis that the chronic stage of TBI was
accompanied by upregulation of activated microglia cells (MHC
ll+), gray and white matter areas were examined such as cortex,
striatum, thalamus, olfactory bulb, dentate gyrus, corpus callosum,
cerebral peduncle and fornix (Figure 1 and Figure 2). Of note, the
dentate gyrus and olfactory bulbs displayed no detectable OX6-
immunoreactive cells (see also Figure S1 and Figure S2). We
calculated the volume of activated microglia cells (MHC ll +) in the
ipsilateral and contralateral areas using an anti-OX6 antibody.
Chronic TBI produced a robust upregulation in the volume of
MHC II-labeled activated microglia cells in gray matter areas
ipsilateral to TBI, whereas the volume in the contralateral side was
not significantly different to that in sham control (Figure 1A, B, C).
There was a 12-, 7- and a 10-fold increase in the volume of MHC
Class ll in cortex (Figure 1A, D, E), striatum (Figure 1B, F,G), and
thalamus (Figure 1C, H, I), respectively; cortex, F2, 45 = 18.49,
p,0.005; striatum, F2, 45 = 15.71, p,0.005; thalamus, F2,
45 = 12.23, p,0.005. Similar analysis show that chronic TBI
prompted an increase of activated MHC II-positive microglia cell
volume in white matter areas ipsilateral and contralateral to TBI
injury (Figure 2 and Figure S2). Chronic TBI resulted in an
upregulation of activated microglia cells in corpus callosum,
cerebral peduncle, and fornix around the injury side (Figure 2A, B,
and C). There were no significant differences between ipsilateral
and contralateral side of TBI animals, largely due to activation of
microglia cells in corpus callosum in both hemispheres (p’s.0.05;
Figure 2A). Additionally, significant increments in activated MHC
II-positive microglia cells were detected in the ipsilateral cerebral
peduncle (Figure 2A) and the ipsilateral hippocampal fornix
(Figure 2C). ANOVA revealed significant treatment effects on
MHC II-positive cells as follows: corpus callosum, F2, 45 = 5.656,
p,0.05; cerebral peduncle, F2, 45 = 27.39, p,0.0005; fornix, F2,
45 = 5.541, p,0.05. A summary of all areas, comparing sham
control and chronic TBI, is presented in Figure 2D. All data are
represented as mean values 6SEM.
Figure 1. Upregulation of MHCll+ activated microglia cells in gray matter in chronic TBI. Results indicate that there is a clear exacerbation
of activated microglia cells in ipsilateral side of subcortical gray matter regions in chronic TBI relative to contralateral side and sham control. After 8
weeks from initial TBI injury, asterisks denote significant upregulation on the volume of MHC II expressing cells in A) cortex, B) striatum, C) thalamus.
While contralateral side present an estimated volume of activated microglia cells similar to sham control animals. ANOVA revealed significant
treatment effects as follows: cortex, F2,45 = 18.49; ***p,0.005; striatum, F2,45 = 15.71, ***p,0.005, and; thalamus, F2,45 = 12.23, ***p,0.005.
Photomicrographs correspond to representative gray matter in coronal sections stained with OX6 (MHC ll) from ipsilateral sham control and TBI rats,
cortex (Figure 1D, E), striatum (Figure 1F, G), thalamus (Figure 1H, I). Scale bars for D, E, F, G, H, I = 1 mm.
doi:10.1371/journal.pone.0053376.g001
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Chronic TBI Impairs Hippocampal Cell Survival and
Proliferation
Next, in order to test the hypothesis that neuronal cell loss and
impaired cell proliferation accompanied long term chronic TBI,
the total number of surviving neurons in the hippocampal CA3
region, and the estimated number of positive dividing cells within
SVZ and SGZ were examined. We found that long term chronic
TBI significantly affected CA3 cell survival; F2,9 = 10.78, p,0.005,
characterized by decreased neurons in the CA3 area of the
ipsilateral hippocampus relative to sham control; p,0.05
(Figure 3A). There was no significant loss of neurons in the CA3
contralateral to chronic TBI animals compared to sham control
(p.0.05; Figure 3A). Additionally, cell proliferation was examined
by quantifying the cell proliferation marker Ki67 (Figure 3 and
Figure S3). Chronic TBI significantly reduced cell proliferation in
SVZ (F2, 45 = 10.45, p,0.0005) in both the ipsilateral and
contralateral side compared with sham control (p’s,0.05;
Figure 3B). Following this observation of chronic TBI-induced
downregulation in the SVZ, we next inspected the cell prolifer-
ation in the SGZ, another neurogenic niche (Figure 3 and Figure
S3). Again, chronic TBI was found to disturb cell proliferation in
the SGZ (F2, 45 = 3.755, p,0.005). Quantification of cell
proliferation within the SGZ demonstrated that there was a
significant decrease in cell proliferation only in the ipsilateral side
of chronic TBI compared with sham control (p,0.05). The
contralateral SGZ did not show significant decrements in cell
proliferation relative to sham control (p.0.05). The dentate gyrus
(see Figure S3) and olfactory bulb (not shown) did not display overt
cell loss.
Chronic TBI does not Affect Neuronal Differentiation in
Neurogenic Niches
Since chronic TBI induced extensive downregulation of cell
proliferation in the two main neurogenic niches (SVZ and SGZ),
neuronal differentiation was examined. Although there appeared a
general downregulation of DCX-positive cells, the fraction of new
cells generated in the SVZ and SGZ initiating down the neuronal
path seems to be similar in the control compared to the TBI
conditions (Figure 4A and B). Chronic TBI did not significantly
impair cellular differentiation into neuronal lineage in the
ipsilateral SVZ and SGZ when compared with the corresponding
contralateral side or with sham control animals (p.0.05).
Discussion
The present study demonstrated long-term neuroinflammation
accompanied chronic TBI, which was closely associated with
neuronal cell loss and impaired cell proliferation in discrete brain
areas adjacent to and even in remote structures from the core
injured region. At eight weeks post-TBI, a significant upregulation
of activated microglia cells was detected not only in the directly
TBI impacted cortical site, but also in proximal adjacent ipsilateral
Figure 2. Upregulation of MHCll+ activated microglia cells in white matter in chronic TBI. Results indicate that there is an upregulation of
activated microglia cells after 8 weeks post TBI in proximal white matter areas. There is an upregulation of MHCll+ cells in the ipsilateral and
contralateral side of corpus callosum relative to sham control (Figure 2A). In contrast, upregulation of MHCll+ activated microglia cells in the cerebral
peduncle (Figure 2B) and fornix (Figure 2C) is only present in the ipsilateral side as compared with the contralateral and sham control. There were no
significant differences between contralateral side and sham control animals in (Figure 2B) and (Figure 2C). ANOVA revealed significant treatment
effects as follows: corpus callosum, F2,45 = 5.656; *p,0.05; cerebral peduncle, F2,45 = 27.39, ***p,0.0005, and; fornix, F2,45 = 5.541, *p,0.05.
Representative photomicrographs, ipsilateral corpus callosum, sham-control Figure 2E and TBI Figure 2F, ipsilateral cerebral peduncle, sham-control
Figure 2G and TBI Figure 2H, and ipsilateral Fornix, sham-control Figure 2I and TBI Figure 2J. Scale bars for Figure 2E, F, G, H, I, J = 1 mm. A summary of
MHCll+ estimated volume is presented capturing different subcortical regions; including those proximal and distal from TBI insult (Figure 2D). Chronic
TBI greatly upregulates the neuroinflammation in the thalamus expressing the highest upregulation of MHCll+ activated microglia cells, despite its
distal subcortical location. Strong expression of MHCll+ activated microglia cells is also detected in the corpus callosum and striatum (Figure 2D).
doi:10.1371/journal.pone.0053376.g002
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areas as well as in distal areas from injury. In tandem, a significant
decrease of hippocampal neurons in the CA3 region ipsilateral to
injury was detected relative to sham control. There was no cell loss
found in the contralateral side after chronic TBI in the CA3
region. Examination of the neurogenic niches revealed significant
declines in cell proliferation in both SVZ and SGZ ipsilateral to
TBI. Of note, only the contralateral side of SVZ, but not the SGZ,
seemed to be affected by chronic TBI showing a 40% decreased in
cell proliferation compared with sham control. The present
location of chronic inflammation seems to correlate with the
observed cell loss and impaired cell proliferation. The SVZ and
the dorsal hippocampus are located proximal to the area of CCI in
the cortex. In addition, the proximity of the fornix and corpus
callosum and thalamus to the hippocampus might have affected
the CA3 cell survival and SGZ cell proliferation due to the chronic
activated microglia cells present in these regions.
Neurodegeneration after the initial insult in TBI involves acute
and chronic stages. Cell death processes in acute, but not chronic
Figure 3. Hippocampal CA3 cell loss and downregulation of cell proliferation. H&E staining revealed a significant cell loss in the
hippocampal CA3 region after chronic TBI (Figure 3A). Ki67, a cell proliferation marker, revealed a significant chronic TBI-related decrease in the SVZ
of cell proliferation only in the ipsilateral side relative to contralateral side and sham control animals (Figure 3B). Contralateral measurements revealed
that cell proliferation also decrease, but it does not show significant differences when compared with sham control animals (Figure 3B). Also, Ki67
revealed a significant decrease in cell proliferation in the SGZ of the hippocampus in the ipsilateral side compared to sham control (Figure 3C). In
summary, ANOVA revealed significant treatment effects as follows: Hippocampal CA3 neurons, F2,9 = 10.78, ***p,0.005; SVZ, F2,45 = 10.45,
***p,0.005, and; SGZ, F2,45 = 3.755, ***p,0.005. Representative photomicrographs from coronal sections ipsilateral CA3 region stained with
hematoxylin/eosin in sham control and TBI rats (Figure 3D, E). Ipsilateral SVZ from sham-control and TBI rats (Figure 3F, G) and ipsilateral SGZ from
sham-control and TBI rats (Figure 3H, I) are shown. Scale bars for Figures 3D, E, F, G, H, I = 50 mm.
doi:10.1371/journal.pone.0053376.g003
Figure 4. Neural differentiation is not affected by chronic TBI. DCX staining, neural differentiation marker revealed that there is not
significant impairment in neural differentiation in either SVZ of the lateral ventricle, or the SGZ of the hippocampus relative to contralateral side and
sham control animals. The ‘‘ns’’ denotes non-significant differences (p.0.05). Representative coronal sections from ipsilateral SVZ stained with DCX in
sham control and TBI rats (Figure 4C, D) and SGZ from sham-control and TBI rats (Figure 4E, F) are shown. Scale bars for Figure 4C, D, E, F = 50 mm.
doi:10.1371/journal.pone.0053376.g004
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stages of TBI, as revealed by the CCI model, have been well
characterized [5,22,23,24]. Acute primary injury manifestations
start to appear during the early stages of TBI, characterized by
elevated intracerebral pressure, ruptured blood brain barrier,
brain edema, and reduced cerebral blood flow at the area of injury
[28,29,30]. In addition, at the molecular level, a massive innate
immune response appears within minutes to ease elimination of
cellular debris [24]. This wave of progressive injury contributes to
long-term progressive damage post-TBI in animals and is seen also
in patients even decades after the injury [6,8,9,27]. After acute
head trauma, increased cell proliferation and neural differentiation
were detected within the neurogenic niches (SVZ and SGZ), likely
corresponding to an endogenous regenerative mechanism to
provide neuroprotection at the site of injury
[3,31,32,33,34,35,36]. The recognition that the chronic stage of
neuroinflammation alters endogenous reparative mechanism, i.e.,
proliferative properties of neurogenic niches especially the SVZ
[38], requires the development of new strategies to mobilize these
proliferative cells to specific injured brain areas for regenerative
purposes [38]. Of note, only 10% of new cells in the SGZ survive
for up to 4 weeks post injury in a close head injury mouse model of
focal TBI, and 60% of new cells in the pericontusional cortex
become astrocytes in response to brain injury [32,33]. Addition-
ally, a decreased survival of immature neurons can be seen as early
as 7 days, in a mouse model of moderate TBI, and then at 4 weeks
post-TBI both cell proliferation and neural differentiation greatly
declined relative to sham control mice [37]. The observed
preferential effect of TBI on cell proliferation, but not neuronal
differentiation, may be due to a fraction of new cells undergoing
neurogenesis not affected by TBI, even though overall prolifera-
tion rates are substantially reduced. In particular, this fraction of
new cells generated in the SVZ and SGZ committed towards the
neuronal lineage remains active in both control and TBI
conditions. The type of insult (TBI, radiation, neurotoxin) may
affect the brain microenvironment with varying levels of signaling
cues for cell proliferation and differentiation, in turn resulting in an
imbalance of new dividing cells and cells differentiating to a
neuronal phenotype. This hypothesis clearly warrants further
investigations.
Progressive injury to hippocampal, cortical, and thalamic areas
contributes to long-term cognitive damage post-TBI as noted in
military men and in civilian patients even decades after the injury
[5,6,8,9,22,24,25,26,27,30]. It is well recognized that hippocampal
cell loss is a consequence of TBI [39,40]. TBI patients have been
shown to exhibit deficits in verbal declarative memory, which is
modulated in part by the hippocampal formation, and executive
functioning [41,43]. Neuropsychological tests performed in US
Army soldiers after deployment revealed that TBI is closely
associated with functional impairments, while TBI co-morbid with
PTSD and depression presents with chronic long lasting cognitive
deficits [26]. In addition, cognitive functions modulated by the
thalamic-cortical areas of the brain are also affected by chronic
TBI as revealed by high resolution tensor magnetic resonance
imaging [42]. Patients with a history of brain injury exhibit ventral
thalamic atrophy, which correlates with impaired executive
function, attention, and memory and learning deficits post-TBI
[42]. Interestingly, cerebral blood flow to the thalamus is
significantly reduced even by mild TBI and coincides with
impairments in speech, learning and memory [43]. Taken
together, impaired cognitive functions mediated by cortex,
hippocampus, and thalamus may manifest in chronic TBI.
In the present study, cell proliferation was significantly affected
by the cascade of events in chronic TBI, but while neuronal
differentiation showed a trend of similar reduction, it did not reach
statistical significance compared to sham control. These discrepant
results may be due to the timing of histological analyses (acute vs.
chronic), varying models of TBI (mild vs. moderate) and different
animal species (mice vs. rat) [31,32,33,37]. Despite the variability
in experimental procedures and animal subjects, these studies,
including ours, identify the susceptibility of newly formed cells
within neurogenic niches, implicating the pivotal role of endog-
enous cells likely involved in the host reparative mechanism
against TBI [37,38].
Similar co-morbidity critical factors in the clinic, such as patient
age, injury severity, and past medical history, influence the
outcomes of TBI; however, neuroinflammation as a key cell death
exacerbating factor appears consistent following brain injury
[6,8,9,10,11,16,44,45]. Upregulation of neuroinflammation in the
present study was depicted by exacerbation of activated microglia
cells in gray matter structures such as cortex, striatum, thalamus,
and white matter including corpus callosum, fornix and cerebral
peduncles. In the clinic, long-term microglia activation was
visualized in vivo within the thalamus, putamen, occipital cortices,
and white matter areas as the internal capsule, in patients
exhibiting severe impairments in cognitive function up at least 11
months after moderate to severe TBI [44]. Consequently,
microglial cells pose as a candidate target for abrogating cell
death in an effort to develop novel anti-inflammation-based
therapeutic modalities in TBI [4,6,7,8,9,10].
The present findings of white matter changes, in chronic TBI,
agree with previous reports demonstrating the negative influences
of activated microglial cells after TBI [46,47,48]. White matter
axonal injury is a very common feature in clinical setting after
TBI, which accounts for impairments of cognitive function, and
may result in high mortality rate [46,47,48]. Axonal degeneration,
typical in white matter injury, interrupts the action potential
throughout the cortex [46,47,49], and combined with overt
activation of microglia cells in cortical and subcortical areas, may
lead to impaired cell survival and cell proliferation in both
immediate and remote areas of the impacted brain region
[8,9,23,50,51]. In the present in vivo study, there were 70% and
34% decrements in cell proliferation in the SVZ and SGZ,
respectively, in comparison to sham control. Our study suggests
that cell proliferation is altered due to chronic neuroinflammation,
but additional studies elucidating this cell death mechanism and its
direct influence on impeding endogenous proliferation would be
necessary to establish this point. Notwithstanding, these results
advance the potential benefits of anti-inflammatory therapies
during the chronic stage of TBI.
Taken together, these results indicate that while TBI is generally
considered an acute injury, a chronic secondary cell death
perturbation (i.e., neuroinflammation) and a diminished endoge-
nous repair mechanism (i.e., cell proliferation) accompany the
disease pathology over long-term. The recognition of long-term
pathological disturbances associated with chronic inflammation
and neuropsychological diseases suggests a vigilant follow-up
monitoring of TBI patients in order to better manage the disease
progression. A multi-pronged treatment targeting inflammatory
and cell proliferative pathways may abrogate these chronic TBI
pathological effects.
Supporting Information
Figure S1 Upregulation of MHCll+ activated microglia
cells in gray matter in chronic TBI. Results indicate that
there is a clear exacerbation of activated microglia cells in
ipsilateral side of subcortical gray matter regions in chronic TBI
relative to contralateral side and sham control. After 8 weeks from
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initial TBI injury, asterisks denote significant upregulation on the
volume of MHC II expressing cells in cortex, striatum, and
thalamus. While contralateral side present an estimated volume of
activated microglia cells similar to sham control animals.
Photomicrographs correspond to representative gray matter in
coronal sections stained with OX6 (MHC ll) in sham control and
TBI. Arrows denote activated microglia cells. Upregulation of
MHCll+ activated microglia cells in white matter in
chronic TBI. Results indicate that there is an upregulation of
activated microglia cells after 8 weeks post TBI in proximal white
matter areas. There is an upregulation of MHCll+ cells in the
ipsilateral and contralateral side of corpus callosum relative to
sham control. In contrast, upregulation of MHCll+ activated
microglia cells in the cerebral peduncle and fornix is only present
in the ipsilateral side as compared with the contralateral and sham
control. There were no significant differences between contralat-
eral side and sham control animals. Photomicrographs correspond
to representative coronal sections stained with OX6 in sham
control and TBI. Arrows denote activated microglia cells. Chronic
TBI greatly upregulates the neuroinflammation in the thalamus
expressing the highest upregulation of MHCll+ activated microglia
cells, despite its distal subcortical location. Strong expression of
MHCll+ activated microglia cells is also detected in the corpus
callosum and striatum.
(TIF)
Figure S2 Hippocampal CA3 cell loss and downregula-
tion of cell proliferation. H&E staining revealed a significant
cell loss in the hippocampal CA3 region after chronic TBI (A).
Ki67, (cell proliferation marker) revealed a significant chronic
TBI-related decrease in the SVZ of cell proliferation only in the
ipsilateral side relative to contralateral side and sham control
animals. Contralateral measurements revealed that cell prolifera-
tion also decrease, but it does not show significant differences
when compared with sham control animals. Also, Ki67 revealed a
significant decrease in cell proliferation in the SGZ of the
hippocampus in the ipsilateral side in compared to both
contralateral side and sham control. Representative coronal
sections stained with H&E in sham control and TBI are shown.
Arrows denote neuronal cell loss in hippocampal CA3 area. In
addition, representative images of SVZ and SGZ areas stained
with Ki67 in sham control and TBI are shown. Arrows denote
proliferating cells in SVZ and SGZ.
(TIF)
Figure S3 Neuronal differentiation is not affected by
chronic TBI. DCX staining, neuronal differentiation marker
revealed that there is not significant impairment in neuronal
differentiation in either SVZ of the lateral ventricle, or the SGZ of
the hippocampus relative to contralateral side and sham control
animals. Representative coronal sections stained with DCX in
sham control and TBI are shown. Arrows denote DCX positive
cells in SVZ and in the SGZ.
(TIF)
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